Exclusive - India orders Sun Pharma to halt eye-care drug production at plant after quality lapses

By Rishika Sadam HYDERABAD, Oct 30 (Reuters) - Indian drug regulators ordered Sun Pharmaceutical Industries to stop ...

Orbis International commits to helping improve eye health for more than 18 million people

Global eye care nonprofit Orbis International is committing an estimated US$32 million in financial and technical ...

Medical Associations Call on Alberta Government to Rescind Decision Expanding Optometrists' Surgical Scope

The Canadian Ophthalmological Society (COS), the Eye Physicians and Surgeons Association of Alberta (EPSAA), and the Section ...

The ‘Ghost Wing’ Is the Softer Cat-Eye Trend That’s Taking Over

The classic cat-eye gets a softer, more wearable update.

Dua Lipa Just Made This ‘Midnight Emerald Cat-Eye’ Manicure Winter’s Chicest Trend

And it’s a little spooky too.
Vision Monday

Many Consumers With Dry Eye Self-Manage Their Symptoms, B+L Survey Says

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, announced publication of survey results that ...
Managed Healthcare Executive

DME Treatment Landscape: Anti-VEGF Options and Prioritizing Eye Care in Diabetes

Anti-VEGF therapy remains the standard of care for center-involved DME, yet eye care competes with dialysis, amputations, and ...

Sun Pharma told to halt eye-care drug production at plant after quality lapses: Report

The regulatory agencies' move marks an escalation of the action against Sun Pharma, India's biggest pharmaceutical firm.

Mykita’s New Beverly Hills Store Offers A Glimpse Of The Brand’s Future

Beyoncé and Lady Gaga’s eyewear maker brings its handcrafted frames, and a new dimension of eye care, to Los Angeles’s most coveted retail neighborhood.
Optometry Times

First genotype-guided dry eye trial, PREDICT-1, completes randomization

The licaminlimab trial enrolled 176 patients, two-thirds with a TNFR1 variant tied to stronger response. Data expected late 2026.